Detection of Aβ plaques by a novel specific MRI probe precursor CR-BSA-(Gd-DTPA)n in APP/PS1 transgenic mice

Anatomical Record

Volumn 293, Issue 12, 2010, Pages 2136-2143

  Li, Shuping ^a,b   He, Huijin ^a   Cui, Weigang ^c   Gu, Bing ^c   Li, Jin ^c   Qi, Zengxin ^c   Zhou, Guomin ^c   Liang, Chun min ^c   Feng, Xiao yuan ^a,d  

^a FUDAN UNIVERSITY   (China)

^b No 455 Hospital of PLA   (China)

^c FUDAN UNIVERSITY   (China)

^d FUDAN UNIVERSITY   (China)

Author keywords

A plaques; APP PS1 transgenic mouse; CR BSA (Gd DTPA)n; MRI probe

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; CONGO RED; GADOLINIUM PENTETATE ALBUMIN;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; FLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROFIBRILLARY TANGLE; NEWBORN; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SENILE PLAQUE;

ALBUMINS; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; CONGO RED; CONTRAST MEDIA; DISEASE MODELS, ANIMAL; DRUG COMBINATIONS; GADOLINIUM DTPA; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, TRANSGENIC; MOLECULAR PROBES; NEUROFIBRILLARY TANGLES; PLAQUE, AMYLOID;

MUS MUSCULUS;

EID: 78649703270     PISSN: 19328486     EISSN: 19328494     Source Type: Journal    
DOI: 10.1002/ar.21209     Document Type: Article

References (27)

1. Alzheimer's Association. 2009. Alzheimer's disease facts and figures. Alzheimers Dement 5: 234-270.
2. Ashburn TT, Han H, McGuinness BF, Lansbury PT, Jr. 1996. Amyloid probes based on Congo red distinguish between fibrils comprising different peptides. Chem Biol 3: 351-358.
3. Bignami A, Selkoe DJ, Dahl D. 1984. Amyloid-like (Congophilic) neurofibrillary tangles do not react with neurofilament antisera in Alzheimer's cerebral cortex. Acta Neuropathol 64: 243-250.
4. Burtea C, Laurent S, Vander Elst L, Muller RN. 2008. Contrast agents: magnetic resonance. Handb Exp Pharmacol (185 Pt 1): 135-165.
5. Daldrup-Link HE, Okuhata Y, Wolfe A, Srivastav S, Oie S, Ferrara N, Cohen RL, Shames DM, Brasch RC. 2004. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation. Microcirculation 11: 387-396.
6. Haass C, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8: 101-112.
7. Hadizadeh DR, Gieseke J, Lohmaier SH, Wilhelm K, Boschewitz J, Verrel F, Schild HH, Willinek WA. 2008. Peripheral MR angiography with blood pool contrast agent: prospective intraindividual comparative study of high-spatial-resolution steady-state MR angiography versus standard-resolution first-pass MR angiography and DSA. Radiology 249: 701-711.
8. Higuchi M, Iwata N, Matsuba Y, Sato K, Sasamoto K, Saido TC. 2005. 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8: 527-533.
9. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K. 1998. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4: 97-100.
10. Ishihara T, Zhang B, Higuchi M, Yoshiyama Y, Trojanowski JQ, Lee VM. 2001. Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice. Am J Pathol 158: 555-562.
11. Jack CR, Jr, Garwood M, Wengenack TM, Borowski B, Curran GL, Lin J, Adriany G, Grohn OH, Grimm R, Poduslo JF. 2004. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 52: 1263-1271.
12. Jack CR, Jr, Wengenack TM, Reyes DA, Garwood M, Curran GL, Borowski BJ, Lin J, Preboske GM, Holasek SS, Adriany G, Poduslo JF. 2005. In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice. J Neurosci 25: 10041-10048.
13. Johnson AE, Jeppsson F, Sandell J, Wensbo D, Neelissen JA, Jureus A, Strom P, Norman H, Farde L, Svensson SP. 2009. AZD2184: a radioligand for sensitive detection of beta-amyloid deposits. J Neurochem 108: 1177-1186.
14. Klunk WE, Debnath ML, Pettegrew JW. 1995. Chrysamine-G binding to Alzheimer and control brain: autopsy study of a new amyloid probe. Neurobiol Aging 16: 541-548.
15. Klunk WE, Jacob RF, Mason RP. 1999. Quantifying amyloid beta-peptide (Abeta) aggregation using the Congo red-Abeta (CR-abeta) spectrophotometric assay. Anal Biochem 266: 66-76.
16. Ma W, Hwang KJ, Lee VH. 1993. A fluorescence quenching method for estimating chelating groups in chelate-conjugated macromolecules. Pharm Res 10: 204-207.
17. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. 1987. Albumin labeled with Gd-DTPA. An intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 22: 665-671.
18. Rosen MA, Schnall MD. 2007. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma. Clin Cancer Res 13: 770s-776s.
19. Schmidt ML, Schuck T, Sheridan S, Kung MP, Kung H, Zhuang ZP, Bergeron C, Lamarche JS, Skovronsky D, Giasson BI, Lee VM, Trojanowski JQ. 2001. The fluorescent Congo red derivative, (trans, trans)-1-bromo-2, 5-bis-(3-hydroxycarbonyl-4-hydroxy)styrylbenzene (BSB), labels diverse beta-pleated sheet structures in postmortem human neurodegenerative disease brains. Am J Pathol 159: 937-943.
20. Schmiedl U, Ogan MD, Moseley ME, Brasch RC. 1986. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: and experimental study in rats. AJR Am J Roentgenol 147: 1263-1270.
21. Small DH, Cappai R. 2006. Alois Alzheimer and Alzheimer's disease: a centennial perspective. J Neurochem 99: 708-710.
22. Steensma DP. 2001. "Congo" red: out of Africa? Arch Pathol Lab Med 125: 250-252.
23. Styren SD, Hamilton RL, Styren GC, Klunk WE. 2000. X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology. J Histochem Cytochem 48: 1223-1232.
24. Turetschek K, Floyd E, Helbich T, Roberts TP, Shames DM, Wendland MF, Carter WO, Brasch RC. 2001. MRI assessment of microvascular characteristics in experimental breast tumors using a new blood pool contrast agent (MS-325) with correlations to histopathology. J Magn Reson Imaging 14: 237-242.
25. Wadghiri YZ, Sigurdsson EM, Sadowski M, Elliott JI, Li Y, Scholtzova H, Tang CY, Aguinaldo G, Pappolla M, Duff K, Wisniewski T, Turnbull DH. 2003. Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 50: 293-302.
26. Wu X, Feng Y, Jeong EK, Emerson L, Lu ZR. 2009. Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice. Pharm Res 26: 2202-2208.
27. Zhang YZ, Xiang X, Mei P, Dai J, Zhang LL, Liu Y. 2009. Spectroscopic studies on the interaction of Congo red with bovine serum albumin. Spectrochim Acta A Mol Biomol Spectrosc 72: 907-914.